Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the Financial Results ....
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories has informed the stock exchanges that its Board of Directors will meet on Wednesday, February 11, 2026. The key agenda is to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and nine months ended December 31, 2025 (Q3 FY26 results). The company has also confirmed that the trading window for dealing in securities remains closed until February 13, 2026, in line with insider trading regulations. The intimation has been filed under Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine regulatory intimation and does not by itself impact the stock price. Investors should watch for the actual Q3 FY26 results, which will be disclosed after the board meeting on February 11, 2026.